Although it was the COVID-19 pandemic that pushed decentralized clinical trials (DCTs) to the forefront, they had been around for nearly a decade. And while DCTs may increase access to and diversity in clinical trials, study sponsors must ensure participants are safe and protected, while maintaining data integrity.

You can also download the PDF by clicking the button below

When you hear DCT, you automatically think it’s going to be more convenient.
Teonna Woolford, CEO of SCRed

Related resources


The Need for Clinical Trial Diversity

Clinical trial diversity, the inclusion of underrepresented segments of the population in medical research, is a crucial component of health equity.


Supporting Diversity in Clinical Trial Recruitment

See how the Citeline Connect Recruitment Collective partnership network drives study awareness and participation globally.

SEP 06, 2023

Technology & the Triple Aim of Trial Recruiting

The search for a clinical trial match has led patients and caregivers online. All stakeholders must be connected and vetted via available technology.